Kadimastem soars on $7m Korean stem cell investment – Globes
Globes |
Kadimastem soars on $7m Korean stem cell investment
Globes Corestem was founded in 2003 and deals with research, development and marketing of stem cell-based technologies in the field of cell therapy. It currently markets the ALS drug Neuronata-R. The company's portfolio has further products for treatment of … To Lead the Field of ALS Treatment Worldwide: Kadimastem Announces Strategic Collaboration with Korean Biotech … |
